Caio Rocha Lima

Caio Max S. Rocha Lima, MD is Professor of Clinical Medicine at the University of Miami, in the Department of Hematology/Oncology. He received his medical degree from the Federal University of Bahia-Salvador and later pursued residency training at the Clinical Hospital of Sao Paulo University; both in his native country of Brazil. Afterwards, Dr. Rocha Lima completed a fellowship in hematology/oncology at the Medical University of South Carolina. Dr. Rocha Lima was an assistant Professor of Medicine at MUSC and later at Moffitt Cancer Center in Tampa, Fl. At the University of Miami, Dr. Rocha Lima is the Program Leader for Pancreatic/Hepatobiliary and Colorectal Cancer Site Disease Groups. He also co-leads the Phase I program at the University of Miami. Dr. Rocha Lima’s professional memberships include the American Society of Hematology, The American Society of Clinical Oncology, the East Cooperative Oncology Group, and the European Society of Medical Oncology, where he served as the USA ASCO representative in 2002-2003.

Dr. Rocha Lima has engaged in a considerable number of studies that investigate the use of novel agents to treat solid tumors, including pancreatic cancer, lung cancer, and colorectal cancers. He is currently involved as a principal or co-investigator in 20 clinical trials. Dr. Rocha Lima’s research has been widely published in journals such as Journal of Clinical Oncology, Chest, Oncology, Seminars in Oncology, Cancer, and The Annals of Oncology.